Abstract
The relation between basal and inducibleβ-lactamase production and resistance toβ-lactam compounds was studied in five clinicalPseudomonas aemginosa isolates and their corresponding resistant variants selected in the presence of either piperacillin, ceftazidime or aztreonam. In all wild-type strains enzyme levels were barely detectable in the uninduced state and mostβ-lactams, including sulbactam and clavulanic acid, exhibited poor induction potency. Imipenem proved to be the most potent inducer in both these strains and their resistant variants. In the variants selected by either piperacillin or ceftazidime enzyme production amounted to 1.28 units/mg protein of the cell-free supernatants following the addition ofβ-lactams as inducers. Additionally, these variants exhibited the phenomenon of “non-specific” induction, i.e. the increase of enzyme production by either a complex nutrient medium or by addition of vitamins. Enzyme production in the aztreonam-resistant variants was identical to that in the wild-type strains with a single exception, where the entire derepression ofβ-lactamase production in one of the variants took place. Derepression of the chromosomally mediated enzyme affects the susceptibility to ureidopenicillins more than that to carboxy-penicillins and cephalosporins, whereas theβ-lactamase-independent resistance results in increased resistance to allβ-lactams with the single exception of imipenem.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sabath, L. D., Jago, M., Abrahams, E. P.: Cephalosporinase and penicillinase activities of aβ-lactamase fromPseudomonas aeruginosa. Biochemical Journal 1965, 96: 739–752.
King, A., Shannon, K., Eykyn, S., Phillips, I.: Reduced sensitivity toβ-lactam antibiotics arising during ceftazidime treatment ofPseudomonas aeruginosa infections. Journal of Antimicrobial Chemotherapy 1983, 12: 363–370.
Bryan, L. E., Kwan, S., Godfrey, A. J.: Resistance ofPseudomonas aeruginosa mutants wilh altered control of chromosomal beta-lactamasc to piperacillin, ceftazidime, and cefsulodin. Antimicrobial Agents and Chemotherapy 1984, 25: 382–384.
Livermore, D. M.: β-lactamase induction inPseudomonas aeruginosa by imipenem and its influence on susceptibility tests. In: Ishigami, J. (ed.): Recent advances in chemotherapy. University of Tokyo Press, Tokyo, 1985, p. 1193–1194.
Lerner, S. A., Quinn, J. P.: Emergence of resistance toβ-lactam antibiotics inPseudomonas aeruginosa during treatment with newβ-lactams. Chemioterapia 1985, IV: 95–101.
Quinn, J. P., Dudek, E. J., DiVincenzo, C. A., Luchs, D. A., Lerner, S. A.: Emergence of resistance to imipenem during therapy forPseudomonas aeruginosa infections. Journal of Infectious Diseases. 1986, 154: 289–294.
Gilardi, G. L.:Pseudomonas. In: Lennettc, E. H., Balows, A., Hausler, W. J., Shadomy, H. J. (ed.): Manual of clinical microbiology. American Society for Microbiology, Washington, D.C., 1985, p. 350–372.
Knippers, R.: Molekulare Genetik. Georg Thieme Verlag, Stuttgart, 1982.
Cullmann, W., Flensberg, Th., Opferkuch, W., Stieglitz, M., Wiedemann, B.: Correlation ofβ-lactamase production and resistance toβ-lactam antibiotics inEnterobacteriaceae. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene (A) 1982, 252: 480–489.
Cullmann, W., Dalhoff, A., Dick, W.: Nonspecific induction ofβ-lactamase inEnterobacter cloacae. Journal of General Microbiology 1984, 130: 1781–1786.
Schindler, P., Huber, G.: Use of PADAC, a novel βlactamase substrate for the detection ofβ-lactamase producing organisms andβ-lactamase inhibitors/inactivators. In: Brodbeck, U. (ed.): Enzyme inhibitors. Verlag Chemie, Weinheim, 1981.
Choma, C. T., Yamazaki, H.: Simple assay and extraction of periplasmic penicillinase inEscherichia coli. Canadian Journal of Microbiology 1981, 27: 547–550.
Cullmann, W.: Hydrolysis of third-generation cephalosporins byEnterobacter cloacae, β-lactamase. European Journal of Clinical Microbiology 1985, 4: 607–609.
Dalhoff, A., Cullmann, W.: Specificity ofβ-lactamase induction inPseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 1984, 14: 349–359.
Cullmann, W., Dick, W.: Evidence for nonspecific induction of beta-lactamase in overproducing variants ofEnterobacter cloacae andCitrobacter freundii. European Journal of Clinical Microbiology 1985, 4: 34–40.
Gootz, T. D., Sanders, C. C.: Characterization ofβ-lactamase induction inEnterobacter cloacae. Antimicrobial Agents and Chemotherapy 1983, 23: 91–97.
Ullmann, A., Danchin, A.: Role of cyclic AMP in bacteria. In: Greengard, P., Robison, G. A. (ed.): Advances in cyclic nucleotide research. Raven Press, New York, 1983, p. 1–54.
Gwynn, M. N., Rolinson, G. N.: Selection of variants ofPseudomonas aeruginosa resistant toβ-lactam antibiotics. Infection 1980, 8: 73–80.
Curtis, N. A. C., Eisenstadt, R. L., Rudd, C., White, A. J.: Inducible type Iβ-lactamases of gram-negative bacteria and resistance toβ-lactam antibiotics. Journal of Antimicrobial Chemotherapy 1986, 17: 51–61.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cullmann, W., Büscher, K.H. & Dick, W. Selection and properties ofPseudomonas aeruginosa variants resistant to beta-lactam antibiotics. Eur. J, Clin. Microbiol. 6, 467–473 (1987). https://doi.org/10.1007/BF02013112
Issue Date:
DOI: https://doi.org/10.1007/BF02013112